{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:34:51Z","timestamp":1783719291893,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.thromres.2018.11.017","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T23:28:58Z","timestamp":1542324538000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Clinical outcomes in hemophilia A patients undergoing tailoring of prophylaxis based on population-based pharmacokinetic dosing"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1126-1498","authenticated-orcid":false,"given":"Azusa","family":"Nagao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy H.T.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Germini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2018.11.017_bb0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2516.2010.02370.x","article-title":"Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia","volume":"17","author":"Collins","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2018.11.017_bb0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/rth2.12118","article-title":"Focusing in on use of pharmacokinetic profiles in routine hemophilia care","volume":"27","author":"Croteau","year":"2018","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.11.017_bb0015","series-title":"The Design and Analysis of Pharmacokinetic Studies of Coagulation Factors","first-page":"1","author":"Lee","year":"2001"},{"key":"10.1016\/j.thromres.2018.11.017_bb0020","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.2196\/resprot.6558","article-title":"Development of a web-accessible population pharmacokinetic service\u2014hemophilia (WAPPS-Hemo): study protocol","volume":"5","author":"Iorio","year":"2016","journal-title":"JMIR Res. Protoc."},{"key":"10.1016\/j.thromres.2018.11.017_bb0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2516.2009.02191.x","article-title":"Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A","volume":"16","author":"Bjorkman","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2018.11.017_bb0030","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.11.017_bb0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2106\/00004623-197759030-00001","article-title":"Hemophilic arthropathy. Current concepts of pathogenesis and management","volume":"59","author":"Arnold","year":"1977","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.thromres.2018.11.017_bb0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/hae.12618","article-title":"Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A","volume":"21","author":"Garc\u00eda-Das\u00ed","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2018.11.017_bb0045","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjh.14072","article-title":"Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study","volume":"174","author":"Schrijvers","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2018.11.017_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2016.04.015","article-title":"Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25\u202fyears and its potential association with bleeding episodes","volume":"143","author":"P\u00e9rez-Robles","year":"2016","journal-title":"Thromb. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481830611X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481830611X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:38:23Z","timestamp":1758735503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481830611X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":10,"alternative-id":["S004938481830611X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2018.11.017","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes in hemophilia A patients undergoing tailoring of prophylaxis based on population-based pharmacokinetic dosing","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2018.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}